Open-label trial with artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria three years after its broad introduction in Jimma Zone, Ethiopia
Main Authors: | Eshetu, Teferi, Abdo, Nasir, Bedru, Kunuz H, Fekadu, Sintayehu, Wieser, Andreas, Pritsch, Michael, Löscher, Thomas, Berens-Riha, Nicole |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438107/ |
Similar Items
-
Possible Clinical Failure of Artemether-Lumefantrine in an Italian Traveler with Uncomplicated Falciparum Malaria.
by: Repetto, Ernestina C., et al.
Published: (2011) -
Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
by: Prakash Ghimire, et al.
Published: (2018-08-01) -
Therapeutic efficacy of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin
by: Ogouyèmi-Hounto, Aurore, et al.
Published: (2016) -
Evaluation of Plasmodium falciparum gametocyte detection in different patient material
by: Kast, Katharina, et al.
Published: (2013) -
In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia
by: Hwang, Jimee, et al.
Published: (2011)